Status:
COMPLETED
Reducing Intersectional Stigma Among High-Risk Women in Brazil to Promote Uptake of HIV Testing and PrEP
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
Santa Casa Medical School
National Institute of Mental Health (NIMH)
Conditions:
HIV Prevention
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
This is a randomized controlled trial of a multi-level intervention to prevent HIV acquisition among transgender women (N=400) in São Paulo, Brazil. The intervention will be evaluated using a randomiz...
Detailed Description
Globally, transgender ('trans') women experience extreme social and economic marginalization due to intersectional stigma, defined as the confluence of stigma that results from the intersection of soc...
Eligibility Criteria
Inclusion
- 18 years or older;
- assigned 'male' at birth but currently identify as female, transgender, transsexual, or travesti (a common identity term among trans women in Brazil);
- not be known to be HIV positive;
- be a resident of the São Paulo area; and
- consent to study procedures, including consent to review their clinical records.
Exclusion
- currently psychotic, suicidal, or manic;
- known to be HIV-positive at enrollment.
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 3 2024
Estimated Enrollment :
392 Patients enrolled
Trial Details
Trial ID
NCT04114955
Start Date
December 1 2020
End Date
October 3 2024
Last Update
November 5 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CRT - Centro de Referência e Treinamento DST/AIDS
São Paulo, Brazil
2
SAE - Serviço de Assistência Especializada Campos Elíseos
São Paulo, Brazil